Evaluation of chronic lymphocytic leukemia by BAC-based microarray analysis
2011

Evaluating Chronic Lymphocytic Leukemia with Microarray Analysis

Sample size: 25 publication 10 minutes Evidence: moderate

Author Information

Author(s): Roger A Schultz, Maria Delioukina, Karl Gaal, Victoria Bedell, David D Smith, Stephen J Forman, Lisa D McDaniel, Blake C Ballif, Lisa G Shaffer, Marilyn L Slovak

Primary Institution: Signature Genomics

Hypothesis

Can BAC-based microarray analysis improve the detection of genetic abnormalities in chronic lymphocytic leukemia (CLL)?

Conclusion

Microarray analysis successfully identified additional genetic abnormalities in CLL cases that were not detected by traditional methods.

Supporting Evidence

  • Microarray analysis detected all copy number imbalances identified by prior cytogenetic studies in 15 out of 25 cases.
  • Additional abnormalities were found in 15 cases, including deletions linked to CLL susceptibility.
  • Microarray analysis was able to detect abnormalities present in as few as 10% of cells.

Takeaway

Researchers looked at 25 patients with a type of blood cancer called CLL and found that a special test could spot more genetic problems than older tests.

Methodology

The study used BAC-based microarray comparative genomic hybridization (aCGH) to analyze genetic samples from patients with CLL.

Potential Biases

The study may be biased towards more severe cases of CLL due to the patient selection from a tertiary care center.

Limitations

Some abnormalities were not detected due to low levels of representation in the samples.

Participant Demographics

Patients diagnosed with chronic lymphocytic leukemia from a tertiary cancer center.

Digital Object Identifier (DOI)

10.1186/1755-8166-4-4

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication